Skin Test Hypersensitivity Study of a Cross‐linked, Porcine Collagen Implant for Aesthetic Surgery

BACKGROUND The use of bovine collagen implants for dermal contour correction is associated with a 3% to 5% incidence of hypersensitivity, which necessitates pretreatment screening by an intradermal skin test. OBJECTIVE The objective was to determine the incidence of hypersensitivity with the recently developed cross-linked, porcine collagen implant, EVOLENCE (ColBar LifeScience Ltd.), which is used intradermally for correction of rhytids and scars. Materials and Methods Enrolled subjects (n=530) received an intradermal injection of 0.1 mL EVOLENCE implant in the left forearm and a second injection in the right forearm after 2 weeks. Injection sites were assessed clinically at 30 minutes and 72 hours after each injection and at 30 days after the second injection. Serum anticollagen antibody determinations were performed at screening and at the end of the study. RESULTS Study assessments were completed by 519 subjects. No significant erythematous reactions suggestive of positive hypersensitivity were observed. Most subjects did not display antibodies against porcine Type I collagen at any time, and those who did showed no changes in levels during the study. The single-sided 95% upper confidence limit for the possibility of moderate-to-severe erythematous reactions with the EVOLENCE implant was determined as 0.58% of subjects. CONCLUSION Because the EVOLENCE implant has a low potential for hypersensitivity, intradermal skin testing before its use appears unnecessary.

[1]  R. Narins,et al.  Injectable skin fillers. , 2005, Clinics in plastic surgery.

[2]  N. Lowe.  Temporary dermal fillers – European experiences , 2002 .

[3]  N. Lowe.  Textbook of Facial Rejuvenation : The Art of Minimally Invasive Combination Therapy , 2002 .

[4]  N. Lowe,et al.  Hyaluronic acid skin fillers: adverse reactions and skin testing. , 2001, Journal of the American Academy of Dermatology.

[5]  R. G. Paul,et al.  Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. , 1996, The international journal of biochemistry & cell biology.

[6]  F. Delustro,et al.  Evaluation of antibody class in response to bovine collagen treatment in patients with urinary incontinence. , 1996, The Journal of urology.

[7]  C W Hanke,et al.  Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. , 1991, Journal of the American Academy of Dermatology.

[8]  J. Dasch,et al.  Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. , 1990, Clinical orthopaedics and related research.

[9]  E. Eikenberry,et al.  Isolation and partial characterization of collagen chains dimerized by sugar-derived cross-links. , 1988, The Journal of biological chemistry.

[10]  P. Bailin,et al.  Collagen Implantation: Clinical Applications and Lesion Selection , 1988 .

[11]  S. Stegman,et al.  Adverse Reactions to Bovine Collagen Implant: Clinica1 and Histologic Features , 1988 .

[12]  S. T. Smith,et al.  Reaction to Injectable Collagen: Results in Animal Models and Clinical Use , 1987, Plastic and reconstructive surgery.

[13]  J. McPherson,et al.  The human immune response to reconstituted bovine collagen. , 1986, Journal of immunology.

[14]  E. Krull,et al.  Injectable collagen implant--update. , 1983, Journal of the American Academy of Dermatology.

[15]  L. Cooperman,et al.  Injectable collagen: A six-year clinical investigation , 2005, Aesthetic Plastic Surgery.

[16]  A. Klein.  Collagen substances. , 2001, Facial plastic surgery clinics of North America.

[17]  T. Miyata,et al.  Collagen engineering for biomaterial use. , 1992, Clinical materials.

[18]  H. Struck.  Immunological investigations of antigenicity and specificity of soluble collagen fractions. IV. Anaphylaxis and allergy experiments. , 1976, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.